tiprankstipranks
Trending News
More News >

Nyxoah Announces Change in Shareholder Voting Rights

Story Highlights
Nyxoah Announces Change in Shareholder Voting Rights

Confident Investing Starts Here:

An update from Nyxoah ( (NYXH) ) is now available.

On May 30, 2025, Nyxoah SA announced that it received a transparency notification from Vestal Point Capital, indicating an acquisition or disposal of voting securities or rights. As of May 21, 2025, Vestal Point Capital holds 1,809,843 voting rights, representing 4.84% of the total voting rights, just below the 5% threshold. This notification highlights a shift in shareholder structure, which could impact Nyxoah’s governance and decision-making processes.

The most recent analyst rating on (NYXH) stock is a Buy with a EUR19.00 price target. To see the full list of analyst forecasts on Nyxoah stock, see the NYXH Stock Forecast page.

More about Nyxoah

Nyxoah SA is a company operating in the medical technology industry, focusing on the development and commercialization of innovative solutions for the treatment of sleep apnea. The company is known for its implantable neurostimulation devices designed to treat Obstructive Sleep Apnea (OSA) by stimulating the hypoglossal nerve to maintain an open airway during sleep.

Average Trading Volume: 87,776

Current Market Cap: €263.1M

For an in-depth examination of NYXH stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App